Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Hunter Reavis, B.A.

Concepts (54)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Fallopian Tubes220241820.910 Why?
Cystadenocarcinoma, Serous220244500.850 Why?
Ovarian Neoplasms4202448370.640 Why?
Neoplasms, Cystic, Mucinous, and Serous120201990.610 Why?
Peripheral Nerves120204770.570 Why?
Neural Stem Cells120208500.450 Why?
Cell Transformation, Neoplastic1202029420.360 Why?
Epithelial Cells1202036900.310 Why?
Epigenesis, Genetic1202036460.290 Why?
Anoikis12024490.240 Why?
Pyrazines2202112310.240 Why?
Norepinephrine120249090.200 Why?
Tumor Microenvironment2202435840.180 Why?
Pyrazoles2202119730.180 Why?
Hemoglobin, Sickle120161220.140 Why?
Mitosis1202112080.130 Why?
Immunoassay120167520.110 Why?
Neoplasms12020216720.100 Why?
Trans-Activators1202129240.100 Why?
Cell Cycle Proteins1202134610.090 Why?
Anemia, Sickle Cell1201610180.080 Why?
Point-of-Care Systems1201611760.080 Why?
Protein Kinase Inhibitors2202155290.080 Why?
Gene Expression Regulation, Neoplastic2202184260.070 Why?
Erythrocytes1201624540.070 Why?
Neurons1202393350.060 Why?
Disease Progression12020132800.060 Why?
Specific Pathogen-Free Organisms120232260.060 Why?
Phenotype12020163650.050 Why?
Carcinoma, Non-Small-Cell Lung1202152210.050 Why?
Substance P120233350.050 Why?
Antineoplastic Combined Chemotherapy Protocols12019114930.040 Why?
Ovary120239810.040 Why?
Genetic Predisposition to Disease12020174490.040 Why?
Antineoplastic Agents12021136680.040 Why?
Phthalazines120193630.040 Why?
Humans720247442200.040 Why?
Lung Neoplasms12021130960.030 Why?
Breast Neoplasms12023208170.030 Why?
Drug Synergism1201917910.030 Why?
Cell Line, Tumor22023166870.030 Why?
Female320243801970.030 Why?
Multiprotein Complexes1202111190.030 Why?
BRCA1 Protein1201911490.030 Why?
Animals220231687880.030 Why?
Xenograft Model Antitumor Assays1201935570.020 Why?
Survival Analysis12023102500.020 Why?
DNA Damage1201924320.020 Why?
Piperazines1201924910.020 Why?
Mice, Inbred C57BL12023218240.020 Why?
Drug Resistance, Neoplasm1201951690.020 Why?
Disease Models, Animal12023180270.010 Why?
Signal Transduction12021234040.010 Why?
Mice12023811780.010 Why?
Reavis's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (54)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.